Company profile for Oxular

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oxular develops novel drug/device combination treatments for sight threatening retinal diseases. The Company’s innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness. Strategic focus The global retinal therapeutics market is set to surpass $14 billion by 2024. Growth is being driven by: rising prevalence of retinal disease due to aging pop...
Oxular develops novel drug/device combination treatments for sight threatening retinal diseases. The Company’s innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness. Strategic focus The global retinal therapeutics market is set to surpass $14 billion by 2024. Growth is being driven by: rising prevalence of retinal disease due to aging populations and the increasing incidence of diabetes; approval of new and longer lasting treatments; better drug delivery; & better access to healthcare globally Oxular’s development pipeline includes treatments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Magdalen Centre, 1 Robert Robinson Avenue, Oxford OX4 4GA
Telephone
Telephone
+44 (0)1865 636200
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/regeneron-acquires-uk-biotech-adding-oxulars-eye-disease-delivery-tech-portfolio

FIERCE BIOTECH
02 Jan 2025

https://www.businesswire.com/news/home/20221107005193/en

BUSINESSWIRE
07 Nov 2022

https://www.prnewswire.com/news-releases/oxular-appoints-dr-friedrich-asmus-as-chief-medical-officer-301306665.html

PRNEWSWIRE
07 Jun 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty